Daytona Beach, FLNCT07476118Now EnrollingIRB Ready

Obesity Clinical Trial in Daytona Beach, FL

Access cutting-edge obesity treatment through this clinical trial at a research site in Daytona Beach. Study-provided care at no cost to qualified participants.

Sponsored by Eli Lilly and Company

Quick Self-Assessment

See if you qualify for this Daytona Beach location

Preparing your pre-screening questions…

Expert Care in Daytona Beach

Access obesity specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related obesity treatment provided free

Apply for This Daytona Beach Location

Check if you qualify for this obesity clinical trial in Daytona Beach, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Daytona Beach

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Daytona Beach site if eligible
  4. 4Begin participation

About This Obesity Study in Daytona Beach

The main purpose of this study is to evaluate how different dose levels of brenipatide work and how safe they are in healthy people with overweight or obesity. The study will assess the effects of different doses given as subcutaneous (under the skin) injections. Participation in this study will last about 42 weeks.

Sponsor: Eli Lilly and Company

Who Can Participate

Inclusion Criteria

Are overtly healthy with no comorbidities related to body mass index (BMI), such as type 2 diabetes mellitus or unstable cardiovascular disease, as determined by medical evaluation
Have a BMI within the range of 27.0 to 45.0 kilogram per square meter (kg/m\^2)
Have no significant (not more than 5 percent \[%\]) self-reported weight gain or loss in the past 3 months prior to screening

Exclusion Criteria

Have significant history or presence of cardiovascular, respiratory, hepatic, renal, gastrointestinal (GI), endocrine, hematological, dermatological, or neurological disorders capable of significantly altering the absorption, metabolism, or elimination; constituting a risk when taking the Investigational Medical Product (IMP); or interfering with the interpretation of data
Have a prior diagnosis of type 1 or type 2 diabetes mellitus
Have a history of acute or chronic pancreatitis
Have a personal or family history of medullary thyroid carcinoma or have multiple endocrine neoplasia syndrome type 2
Have received a glucagon-like peptide-1 (GLP-1) receptor agonist, glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, GIP/GLP-1/glucagon receptor agonist, or amylin receptor agonist within 6 months prior to screening
Have been treated with prescription and over-the-counter medications, or alternative remedies (including herbal/nutritional supplements), that promote weight loss within 6 months prior to screening
Are pregnant or lactating

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Daytona Beach?

Yes, this clinical trial (NCT07476118) has an active research site in Daytona Beach, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Obesity Treatment Options in Daytona Beach, FL

If you're searching for obesity treatment options in Daytona Beach, FL, this clinical trial (NCT07476118) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Daytona Beach research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obesity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all obesity clinical trials near you to find additional studies recruiting in your area.

More Obesity Trials in Daytona Beach, FL

See all obesity clinical trials recruiting in Daytona Beach — not just this study.

Browse Obesity Trials in Daytona Beach →

Browse More Trials by Condition

Obesity TrialsPediatric Obesity TrialsObesity Hypoventilation Syndrome TrialsAll Conditions →

Ready to Join in Daytona Beach?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Daytona Beach, FL